Duac Gel

Quick links to important sections

Duac Gel

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duac Gel

Property Description
Active Ingredients Benzoyl Peroxide, Clindamycin
Form Gel (Topical Semisolid)
Pharmacological Class Topical Anti-acne Preparation (Antibiotic/Keratolytic Combination)
Origin Synthetic
Type Fixed-dose combination product

What Type of Medicine is Duac Gel? (Identity, Class, and Form)

Duac Gel is a prescription-only topical medication supplied as a fixed-dose combination product specifically intended for dermatological application. This semisolid gel preparation is broadly classified within the Topical Anti-acne Preparations. It is clinically recognized for its unique, single-step approach to treatment, offering both antimicrobial and comedolytic activity. This combination strategy is often preferred in guidelines for managing moderate acne. Using multiple active components together provides a robust therapeutic starting point.


Active Ingredients: What is Duac Gel Made Of? (Composition and Origin)

The medicine is composed of two synthetic active ingredients: Clindamycin (as Clindamycin Phosphate) and Benzoyl Peroxide (INN). Clindamycin acts as the antimicrobial agent, while Benzoyl Peroxide operates as both an oxidizing agent and a keratolytic. This particular formulation is specifically engineered for stability and patient benefit. The formulation's primary differentiation from simple mixed products is that the Benzoyl Peroxide component helps significantly mitigate the risk of bacterial resistance to the Clindamycin component, a frequent concern when topical antibiotics are used in isolation.


What is the General Therapeutic Purpose of the Combination? (Benefits and Mechanism Note)

The general purpose of this dual-mechanism formulation is to provide comprehensive support in acne management by addressing both bacterial proliferation and physical pore blockage. The antimicrobial activity of Clindamycin reduces the population of acne-causing bacteria, such as Propionibacterium acnes, thereby decreasing the severity of red, inflammatory lesions. Concurrently, the comedolytic and oxidizing properties of Benzoyl Peroxide work to clear blocked pores, assisting in the prevention of new non-inflammatory lesions. This balanced therapeutic effort manages the overall appearance and progression of the condition.

What side effects are possible with Duac Gel?

Possible Side Effects and Safety Information

The safety profile for this topical combination is formally structured by frequency categories based on regulatory documentation. The most frequently observed effects are generally localized to the site of application.

Documented Adverse Reactions

Side effects are classified by their frequency and the system-organ class affected. Local skin reactions are the most common occurrences, often peaking during the initial phase of treatment before subsiding.

Frequency Classification Examples (Skin and Subcutaneous Tissue Disorders)
Very Common (ge1/10) Erythema (redness), Skin peeling, Dryness
Common (ge1/100 to <1/10) Burning sensation, Application site reaction
Uncommon (ge1/1,000 to <1/100) Dermatitis, Pruritus (itching), Worsening of acne

Serious adverse reactions are reported primarily through post-marketing surveillance. Systemic absorption of the clindamycin component has been shown, and reports include Colitis, specifically pseudomembranous colitis, which may be severe. Additionally, severe allergic reactions, including anaphylaxis, have been documented.

High-Level Safety Constraints

The medicine is formally contraindicated in individuals with a history of specific gastrointestinal conditions, such as ulcerative colitis or antibiotic-associated colitis. This constraint reflects the potential systemic risk posed by the clindamycin component.

Official labeling states that the product may cause increased sensitivity to sunlight and has the potential to bleach hair or colored fabrics. Furthermore, safety and effectiveness have not been established in pediatric patients under 12 years of age.

Overdose and Emergency Response

Overdose and when to seek help

Overdose scenarios documented in official regulatory labeling are defined by the risks associated with excessive topical application and the potential consequences of accidental ingestion.

Localized Overdose Manifestations

Excessive topical application of the gel may lead to localized overdose manifestations. Official descriptions of these symptoms include severe irritation, redness, and desquamation (peeling) of the skin. For this type of localized exposure, the required action is to discontinue use until the skin has recovered, followed by the use of appropriate symptomatic measures to provide relief.

Systemic Risk and Urgent Action

Accidental oral ingestion carries the potential for systemic absorption of the clindamycin component, which can result in gastrointestinal adverse reactions consistent with systemic antibiotic exposure. The official labeling notes the potential for severe outcomes, including pseudomembranous colitis, which may present as severe diarrhea, bloody diarrhea, or abdominal cramps.

Immediate Medical Help Mandates

Discontinue use immediately and contact a physician if any signs of a severe allergic reaction, such as severe swelling or shortness of breath, are observed. Furthermore, urgent medical investigation is required if prolonged or significant diarrhea or abdominal cramps develop. The management for accidental ingestion is defined as symptomatic and supportive, as no specific antidote is documented in the regulatory information.

Therapeutic Uses of Duac Gel

This combination medication is applied in addressing inflammatory acne.


What Duac Gel Treats: Main Uses and Benefits

Addressing Inflammatory Acne and Breakouts

This therapeutic domain is commonly used across conditions presenting with acute episodes, helping address symptom clusters related to redness, swelling, and inflammatory spots. Applied across domains where additional symptomatic support is needed, this medicine supports the management of heightened physiological activity associated with the condition. The gel is relevant when supportive symptom management is appropriate, assisting with maintaining functional stability. Therapeutic domains are relevant in situations involving both episodic inflammatory manifestations and localized discomfort due to blemishes.

“It provides supportive relief when symptoms interfere with routine activities, contributing to easing the overall symptom load during flare-ups.”

Supporting Comfort During Blemish Manifestations

This medication is applied in contexts marked by increased discomfort or tension related to blackheads and whiteheads, and is relevant for easing symptoms that interfere with daily comfort. Commonly used when short-term symptomatic assistance is needed, it may assist with improving day-to-day comfort during symptomatic periods and supports general well-being during symptomatic phases.

Quick Fact
Assistance for Inflammatory Symptoms

Eligibility and Restrictions for Use

Eligibility and Contraindications for Duac Gel

Official regulatory guidelines define specific populations who are approved to use Duac Gel and those who are strictly prohibited. The medicine is indicated for use in adults and adolescents aged 12 years and older for the topical treatment of acne vulgaris. Safety and efficacy have not been established for children under the age of 12, and its use is generally not recommended in this group.

Absolute Contraindications

Duac Gel must not be used by individuals with a history of the following conditions, as they constitute absolute contraindications in the official labeling:

  • Hypersensitivity or Allergy: Known allergy to either active component, clindamycin or benzoyl peroxide, or to the related antibiotic lincomycin.
  • Inflammatory Bowel History: A history of specific inflammatory bowel conditions, including regional enteritis, ulcerative colitis, or antibiotic-associated colitis (e.g., pseudomembranous colitis).

Conditional Use

Population Regulatory Status
Pregnancy Use is conditional; permitted only if the potential benefit justifies the potential risk to the fetus (FDA Category C).
Lactation/Nursing Conditional use is permitted; the gel must not be applied to the breast area during breastfeeding.

Older adults (65 years and over) have insufficient data documented in clinical trials to establish a differential response, although no specific restriction is mandated.

What should I know about interactions with other medicines?

The official regulatory documents define specific interaction constraints for Duac Gel, primarily involving other dermatological products and substances with systemic effects.

Interaction Scope

Classification Interacting Product or Substance Regulatory Context
Avoid Combination Erythromycin-containing products Documented in vitro antagonism with the clindamycin component.
Avoid Combination Topical Sulfone Products (e.g., Dapsone) Chemical incompatibility that may cause temporary skin and facial hair discoloration.
Use with Caution Other Topical Acne Treatments Potential for cumulative irritancy, especially with peeling or abrasive agents.
Use with Caution Neuromuscular Blocking Agents Clindamycin has properties that may potentiate the effect of these agents upon systemic absorption.
Contraindicated Lincomycin Risk of cross-hypersensitivity to the related antibiotic.

Interaction-related restrictions: Co-administration with other topical acne preparations should be approached with caution due to the risk of additive local irritation and excessive dryness. There are no mandatory administration timing rules explicitly documented in regulatory labeling for this topical product. A formal population-specific constraint exists, as the product is contraindicated in individuals with a history of inflammatory bowel conditions, such as regional enteritis or antibiotic-associated colitis, due to the potential for the absorbed clindamycin to precipitate severe colitis.

Connection to the overall interaction profile: The interaction structure is defined by official warnings against specific combinations due to local chemical incompatibility and pharmacological antagonism, alongside precautions regarding the enhancement of certain systemic drug effects, all as stated in government labeling.

Mechanism of Action

Duac Gel operates through the distinct and complementary actions of clindamycin and benzoyl peroxide, engaging three core mechanistic domains within the pilosebaceous unit.

Modulating Bacterial Protein Synthesis and Inflammation

The clindamycin component is a lincosamide antibiotic that selectively binds to the bacterial 50 S ribosomal subunit. This binding inhibits the synthesis of essential proteins required for the proliferation of C. acnes bacteria. This mechanism not only limits the microbial population but also results in reduced signaling cascade activation driven by inflammatory mediators. This effect contributes to lowering the impact of dysregulated inflammatory mediator release on the surrounding tissue.

Targeted Keratolysis and Oxidative Disruption

The benzoyl peroxide component operates via two mechanistic pathways. First, it functions as a keratolytic agent, increasing the rate of corneocyte shedding. This action involves reducing the cohesion of corneocytes within the follicle, which influences the formation of compacted follicular material. Second, it acts as a non-specific oxidizing agent, releasing free radicals that rapidly induce cell damage and death in C. acnes. This dual action adjusts activity within peripheral pathways associated with follicular epithelial kinetics and microbial viability.

Cascade Mitigation of Antibiotic Resistance

The combination of clindamycin's specific ribosomal targeting and benzoyl peroxide's non-specific oxidative action influences regulatory feedback mechanisms within the microbial population. This interaction is essential for sustaining the drug's effect. This pathway interference is associated with a sustained impact on microbial viability by limiting the emergence of resistance phenotypes against the protein synthesis-inhibiting mechanism.

Dosage and Administration Information

How to Use Duac Gel

Duac Gel is a prescription product strictly intended for topical administration to the skin. It is supplied as a fixed-dose combination gel containing 1.2% Clindamycin and 5% Benzoyl Peroxide, the most common strength, though other strengths exist.

Standard Dosing and Frequency

Administration involves applying a thin layer of the gel to the entire area of skin affected by acne. The labeled dosing frequency is once daily. Instructions typically suggest application in the evening or before bedtime to maintain a consistent daily schedule.

Administration Conditions and Duration

Prior to use, the application site should be gently washed with a mild cleanser and fully dried. It is an explicit instruction that the gel must be kept away from the eyes, mouth, lips, and other mucous membranes, as well as areas of broken or irritated skin.

Treatment with this topical product is generally considered time-limited and should not exceed a maximum of 12 weeks of continuous use in a single course. This limit is a standard usage pattern for topical antibiotic-containing treatments. If the user experiences excessive dryness or peeling, instructions may permit reducing the frequency of application or a temporary interruption of use.

Population-Specific Rules

The established usage pattern is designated for adults and adolescents aged 12 years and above. Safety and administration rules are not established for children under 12 years of age.

Recent Clinical Evidence

Duac Gel: Recent Clinical Evidence

1. Evidence Base for Moderate to Moderately Severe Acne Vulgaris

The research for Duac Gel was evaluated in the context of acne vulgaris in populations characterized by moderate to moderately severe severity. The evidence relies mainly on Randomized Controlled Trials (RCTs), a research type used for examining comparisons. These studies examined the combination gel against a non-medicated gel and against the individual active ingredients, Clindamycin and Benzoyl Peroxide, used alone (monotherapies).

Researchers monitored outcomes related to physical discomfort and inflammatory states. Findings describe patterns observed in the studies related to Investigator Global Assessment (IGA) scores and changes in lesion counts, which included counting both inflammatory and non-inflammatory spots.

2. Long-Term Data and Follow-Up Duration

The duration of observation in pivotal studies was limited to a short-to-intermediate timeframe of 11 to 12 weeks. Because the research examined short-term symptom changes over this defined interval, long-term effects are not fully established. There is limited information for long-term outcomes, and follow-up durations were restricted to this approximate three-month period. Data are still emerging regarding patterns that may occur after this initial assessment, or the durability of observed findings over many months of use.

3. Research Gaps and Specific Populations

The populations observed in the core research typically included adolescents and adults aged 12 years and older. Research applies only to the populations studied and is not designed for individual predictions outside of these specific study groups. Data for certain groups remain insufficient, particularly for older adults with acne or individuals with other co-existing skin conditions.

Furthermore, research findings were mixed regarding the measured change against non-inflammatory lesions (blackheads and whiteheads), with some analyses reporting patterns where the measured change was observed to be similar to Benzoyl Peroxide monotherapy for this specific lesion type.

Frequently Asked Questions (FAQ)

Common questions about Duac Gel (FAQ)

Q: Is Duac Gel the same as using a standard benzoyl peroxide product?

Official studies indicate that the combination product is reported to show greater clinical efficacy in lesion reduction compared to the benzoyl peroxide component when used alone. This is because the dual formulation provides both antibiotic action (clindamycin) and pore-clearing action (benzoyl peroxide) in a single application.

Q: How long do the initial skin irritation side effects typically last?

According to patient information, localized skin reactions like redness, dryness, and peeling are most common during the initial phase of treatment. These effects are expected to subside after the first few weeks as the skin adjusts to the medication.

Q: Can Duac Gel cause the bacteria that cause acne to become resistant to treatment?

Since the gel contains an antibiotic (clindamycin), bacterial resistance is a potential concern when such medications are used. The combination with benzoyl peroxide is intended to help mitigate this risk, which is a key reason for the dual formulation described in regulatory documents.

Q: What type of acne lesions (e.g., blackheads, whiteheads) is Duac Gel officially indicated for?

The medicine is officially indicated for the topical treatment of acne vulgaris. This includes working to reduce both inflammatory lesions (which are typically red spots and bumps) and non-inflammatory lesions (such as blackheads and whiteheads).

Q: What have clinical trials shown regarding patient improvement with Duac Gel?

Studies examined patient outcomes over a typical treatment period of up to 12 weeks. Clinical trials observed reported patterns of reduction in total acne lesion counts and improved overall acne severity compared to the start of the study.

Q: Why is a combination product like Duac Gel sometimes chosen over a single ingredient treatment?

Regulatory information indicates the combination provides a dual-action approach to acne management. This strategy leverages the anti-inflammatory and antibacterial effects of clindamycin along with the pore-clearing and resistance-mitigating effects of benzoyl peroxide.

Q: Is it normal for acne to sometimes appear worse when treatment is first started?

The official documents list 'worsening of acne' as an uncommon side effect, meaning it is reported in less than 1 in 100 people. While initial redness and peeling are common, a true worsening of the condition is described as a less frequent reaction to the medicine.

Q: Does using a large amount of Duac Gel make it work faster?

Official usage instructions state that applying more than the recommended thin layer is noted that it does not clear acne faster. Using excessive amounts of the product is associated with an increased risk of developing skin irritation and other localized side effects.

Q: Does Duac Gel interact with common moisturizers or sunscreens?

Official guidance describes a standard practice of allowing the gel to absorb completely before applying products like moisturizers. Due to the potential for increased sensitivity to sunlight caused by the medicine, regulatory information highlights the importance of consistent sunscreen use.

Q: What types of ingredients in cosmetic products should be avoided while using this medicine?

Official warnings detail the constraint to avoid other topical products that can cause skin irritation while using this medication. This specifically includes substances like harsh soaps, products containing high amounts of alcohol, astringents, or lime.

Q: How long does it usually take to start seeing results from Duac Gel?

Clinical efficacy data suggests that the gel has a fairly rapid onset of action. Clinical observations indicate initial improvements and results are typically seen within 2 to 4 weeks of starting treatment with the product.

Q: When is the treatment considered to be fully effective according to research evidence?

Clinical studies used a treatment duration of up to 12 weeks for evaluating the maximum effect of the product. The continuous use of the medicine is generally limited to this period, as described in regulatory documents for a single course of treatment.

Q: Can Duac Gel be used by people who are known to have sensitive skin?

Official labeling indicates that individuals with fair skin may be particularly susceptible to irritation from the product. The labeling includes a constraint against use by individuals who have a history of sensitivity or intolerance to similar topical products.

Q: Is Duac Gel suitable for use on acne on the chest or back?

Patient information leaflets often include guidance on the application quantities required for treating the face and back. This suggests that the product is generally considered suitable for use on these common acne-prone areas of the body.

Q: What happens if a scheduled application of Duac Gel is missed?

If a scheduled application is missed, official instructions state that the missed dose should be skipped entirely. The regular daily schedule is then continued at the next usual application time; extra gel is not applied to make up for the missed application.

Q: What should be done if Duac Gel is accidentally applied to a sensitive area like the eye?

Official warnings state the gel should be kept away from sensitive areas, including the eyes, mouth, and other mucous membranes. If accidental contact occurs, the specific instruction provided is to rinse the affected area thoroughly with water.

Q: Are there any known issues with combining Duac Gel with oral antibiotics for acne?

Official guidance includes a constraint against combining the medicine with other topical or systemic (oral) antibiotic treatments, unless the combination is specifically directed by a healthcare professional familiar with the patient's full treatment plan.

How should Duac Gel be stored and disposed of?

The storage and disposal of Duac Gel must adhere strictly to regulatory guidelines to maintain its stability.

Storage Requirements

Condition Requirement
Unopened (Prior to Dispensing) Store in a refrigerator (2 C to 8 C)
Opened (After Dispensing) Store at room temperature, not above mathbf25 C
Freezing Do not freeze the product
Container Keep the tube tightly closed and out of the reach of children

Stability and Disposal

The product has a limited shelf-life once opened. Any unused Duac Gel must be discarded after 2 months (60 days) from the date of dispensing or first opening. Expired or unused product should be safely thrown away according to local regulations. A specific handling advisory states the gel may bleach hair or colored fabric.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Duac Gel found in:

A-Z Index: